Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8107
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSofiatul Aini, Nur-
dc.contributor.authorDhea Kharisma, Viol-
dc.contributor.authorHermawan Widyananda, Muhammad-
dc.date.accessioned2024-11-19T06:42:10Z-
dc.date.available2024-11-19T06:42:10Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/8107-
dc.description.abstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the COVID-19 pandemic that infects humans and attacks the body's immune system. The purpose of the study was to identify the potential of bioactive compounds in purslane (Portulaca oleracea L.) and star anise (Illicium verum Hook) via a dual inhibitor mechanism against SARS-CoV-2 proteases with an in silico approach. The samples were obtained from PubChem and RSCB PDB. Antivirus probability prediction was performed on PASS Online. Virtual screening was performed with PyRx via molecular docking. Visualization was used by PyMol and Discovery Studio. Compounds with the best antiviral potential are indicated by the low binding affinity value to the target proteins, namely SARS-CoV-2 TMPRSS2 and PLpro. The results showed that purslane luteolin has the best antiviral potential. However, further studies are required to validate this computational prediction. Key words: SARS-CoV-2, Portulaca oleracea L., Illicium verum Hook, In silico, Antiviral agenten_US
dc.subjectSARS-CoV-2,en_US
dc.subjectPortulaca oleracea L.,en_US
dc.subjectIllicium verum Hook,en_US
dc.subjectIn silico,en_US
dc.subjectAntiviral agenten_US
dc.titleBioactive Compounds from Purslane (Portulaca oleracea L.) and Star Anise (Illicium verum Hook) as SARS-CoV-2 Antiviral Agent via Dual Inhibitor Mechanism: In Silico Approachen_US
dc.typeArticleen_US
Appears in Collections:VOL 14 NO 4 2022

Files in This Item:
File Description SizeFormat 
14.pdf512.7 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.